Previous close | 42.73 |
Open | 42.93 |
Bid | 41.31 x 200 |
Ask | 41.78 x 200 |
Day's range | 40.97 - 42.93 |
52-week range | 16.96 - 73.00 |
Volume | |
Avg. volume | 313,529 |
Market cap | 1.141B |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.17 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 66.67 |
Amid a backdrop of weakening manufacturing signals and fluctuating market sentiments, the U.S. stock market presents a complex landscape for investors. In such uncertain times, growth companies with high insider ownership can be particularly noteworthy as these insiders may have a vested interest in the company's long-term success, aligning their goals closely with those of external shareholders.
Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) is possibly approaching a major achievement in its business, so we...
NEW YORK, May 23, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences.